193 related articles for article (PubMed ID: 27912993)
1. Rehabilitation in Chronic Graft-Versus-Host Disease.
Smith SR; Asher A
Phys Med Rehabil Clin N Am; 2017 Feb; 28(1):143-151. PubMed ID: 27912993
[TBL] [Abstract][Full Text] [Related]
2. Musculoskeletal, Neurologic, and Cardiopulmonary Aspects of Physical Rehabilitation in Patients with Chronic Graft-versus-Host Disease.
Smith SR; Haig AJ; Couriel DR
Biol Blood Marrow Transplant; 2015 May; 21(5):799-808. PubMed ID: 25445027
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous graft-versus-host disease after hematopoietic stem cell transplant - a review.
Villarreal CD; Alanis JC; Pérez JC; Candiani JO
An Bras Dermatol; 2016; 91(3):336-43. PubMed ID: 27438202
[TBL] [Abstract][Full Text] [Related]
4. Relapsing polymyositis in chronic graft versus host disease.
Sharaf N; Prayson RA
J Clin Neurosci; 2014 Nov; 21(11):1964-5. PubMed ID: 24980629
[TBL] [Abstract][Full Text] [Related]
5. Vulvovaginal Graft-Versus-Host Disease.
Kornik RI; Rustagi AS
Obstet Gynecol Clin North Am; 2017 Sep; 44(3):475-492. PubMed ID: 28778644
[TBL] [Abstract][Full Text] [Related]
6. Acute and chronic Graft-versus-host disease after hematopoietic stem cell transplantation.
Funke VA; Moreira MC; Vigorito AC
Rev Assoc Med Bras (1992); 2016 Oct; 62 Suppl 1():44-50. PubMed ID: 27982319
[TBL] [Abstract][Full Text] [Related]
7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
8. Graft-Versus-Host Disease: an Update on Functional Implications and Rehabilitation Interventions.
Brothers L; Malhotra J; Andrews C; Smith SR
Curr Oncol Rep; 2023 Mar; 25(3):145-150. PubMed ID: 36680673
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation.
Ikegame K; Yoshihara S; Taniguchi Y; Kaida K; Inoue T; Okada M; Taniguchi K; Hasei H; Tamaki H; Fujioka T; Kato R; Soma T; Ogawa H
Exp Hematol; 2011 Aug; 39(8):880-90. PubMed ID: 21689724
[TBL] [Abstract][Full Text] [Related]
10. Concise review: the bone marrow niche as a target of graft versus host disease.
von Bonin M; Bornhäuser M
Stem Cells; 2014 Jun; 32(6):1420-8. PubMed ID: 24585665
[TBL] [Abstract][Full Text] [Related]
11. Extracorporeal Photopheresis for Non-skin GvHD.
Bittenbring J; Reichrath J
Anticancer Res; 2016 Mar; 36(3):1395-6. PubMed ID: 26977041
[TBL] [Abstract][Full Text] [Related]
12. Chronic graft-versus-host disease.
Lee SJ; Vogelsang G; Flowers ME
Biol Blood Marrow Transplant; 2003 Apr; 9(4):215-33. PubMed ID: 12720215
[TBL] [Abstract][Full Text] [Related]
13. Chronic cutaneous graft-versus-host disease in children: A report of 14 patients from a tertiary care pediatric dermatology clinic.
Nanda A; Husain MAA; Al-Herz W; Almekaimi A; Al-Sabah H; Al-Otaibi M
Pediatr Dermatol; 2018 May; 35(3):343-353. PubMed ID: 29536565
[TBL] [Abstract][Full Text] [Related]
14. Established and Emerging Treatments of Skin GvHD.
Link-Rachner CS; Sockel K; Schuetz C
Front Immunol; 2022; 13():838494. PubMed ID: 35185931
[TBL] [Abstract][Full Text] [Related]
15. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.
Rocha V; Wagner JE; Sobocinski KA; Klein JP; Zhang MJ; Horowitz MM; Gluckman E
N Engl J Med; 2000 Jun; 342(25):1846-54. PubMed ID: 10861319
[TBL] [Abstract][Full Text] [Related]
16. Ocular graft-versus-host disease: a review.
Shikari H; Antin JH; Dana R
Surv Ophthalmol; 2013; 58(3):233-51. PubMed ID: 23541042
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and clinical management of chronic graft-versus-host disease.
Martin PJ; Carpenter PA; Sanders JE; Flowers ME
Int J Hematol; 2004 Apr; 79(3):221-8. PubMed ID: 15168588
[TBL] [Abstract][Full Text] [Related]
18. How I treat chronic graft-versus-host disease.
Vogelsang GB
Blood; 2001 Mar; 97(5):1196-201. PubMed ID: 11222360
[TBL] [Abstract][Full Text] [Related]
19. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis.
Cutler C; Giri S; Jeyapalan S; Paniagua D; Viswanathan A; Antin JH
J Clin Oncol; 2001 Aug; 19(16):3685-91. PubMed ID: 11504750
[TBL] [Abstract][Full Text] [Related]
20. Graft-versus-host disease: a complex long-term side effect of hematopoietic stem cell transplant.
Barton-Burke M; Dwinell DM; Kafkas L; Lavalley C; Sands H; Proctor C; Johnson E
Oncology (Williston Park); 2008 Oct; 22(11 Suppl Nurse Ed):31-45. PubMed ID: 19856578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]